Article thumbnail
Location of Repository

Association of MICA-TM and MICB C1_2_A Microsatellite Polymorphisms with Tumor Progression in Patients with Colorectal Cancer

By R. Kopp, J. Glas, U. Lau-Werner, E. D. Albert and E. H. Weiss
Topics: Article
Publisher: Springer US
OAI identifier: oai:pubmedcentral.nih.gov:2701994
Provided by: PubMed Central

Suggested articles

Citations

  1. (1998). A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res.
  2. (1994). A second lineage of mammalian major histocompatibility complex class I gene.
  3. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.
  4. Antibodies against MICA antigens and kidney-transplant rejection.
  5. Clinicopathological significance of major histocompatibility complex class I-related chain a and B expression in thyroid cancer.
  6. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA.
  7. Cutting edge: downregulation of MICA on human tumors by proteolytic shedding.
  8. (2009). Decreased NKG2D expression on CD8
  9. Efficient cross-priming of tumor antigen-specific T cells by dendritic cells sensitized with diverse anti-MICA opsonised cells.
  10. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells.
  11. (2009). Generation of antitumor responses by genetic modification of primary human T cells with a chimeric NKG2D receptor.
  12. Human gamma delta T cells: candidates for the development of immunotherapeutic strategies.
  13. I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity.
  14. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
  15. marks the risk for autoimmune Addison's disease.
  16. MHC class I-related chain A conjugated to antitumor antibodies can sensitize tumor cells to specific lysis by natural killer cells.
  17. MICB and C1_4_1 polymorphism in Crohn's disease and ulcerative colitis. Tissue Antigens.
  18. Mutations designed to destabilize the receptor-bound conformation increase MICA-NKG2D association rate and affinity.
  19. (2006). Natural killer cellmediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chainrelated gene A. Hum Gene Ther.
  20. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
  21. Nucleotide sequence of the human MHC class I MICA gene.
  22. receptor stimulate tumour immunity.
  23. Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2Dexpressing cells.
  24. (2003). Roles of the NKG2D immunoreceptor and its ligand. Nat Rev Immunol.
  25. SchrambachS,ArdizoneM,LeymarieV,SibillaJ,BahramS.Invivo expression pattern of MICA and MICB and its relevance to autoimmunity and cancer.
  26. Soluble MICA in malignant diseases.
  27. The increase of MICA gene A9 allele associated with gastric cancer and less schirrous change.
  28. The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection.
  29. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease.
  30. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.
  31. (2001). Typing of all known MICA alleles by group-specific PCR and SSOP. Hum Immunol.
  32. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.